<?xml-stylesheet type="text/xsl" href="varreports_v3.xsl"?><data_table name="l_emppmp_ex08_1_0489s" dataset_id="pht002425.v2" study_name="Framingham Cohort" study_id="phs000007.v30" participant_set="11" date_created="2018/09/17"><description>Endothelial Microparticles, Offspring Cohort Exam 8. Microparticles (MPs) are submicron particles that are released from a cell membrane when the cell undergoes apoptosis or activation. Advanced flow cytometry techniques allow for the identification and quantification of MPs that are derived from certain circulating cell types, including endothelial cells, leukocytes, platelets, and erythrocytes. Quantification of MPs in the Framingham Heart Study was performed on previously frozen and stored samples of platelet-poor plasma collected from participants who attended Offspring Cohort Exam 8. MPs were phenotyped according to a previously described standardized protocol (Hypertension 2006;48:180-6), using fluorochrome-labeled antibodies (Beckman Coulter, France). Flow cytometric analyses was performed on a Coulter EPICS XL flow cytometer, and raw data were analyzed using FlowJo (TreeStar, Inc., Ashland, OR).</description><variable id="phv00163426.v2.p11" var_name="shareid" calculated_type="string" reported_type=""><description>Framingham Heart Study participant SHARe ID number</description><total><subject_profile><sex><male>402</male><female>501</female></sex></subject_profile><stats><stat n="903" nulls="0"/></stats></total></variable><variable id="phv00163426.v2.p11.c1" var_name="shareid" calculated_type="string" reported_type=""><description>Framingham Heart Study participant SHARe ID number</description><total><subject_profile><sex><male>377</male><female>479</female></sex></subject_profile><stats><stat n="856" nulls="0"/></stats></total></variable><variable id="phv00163426.v2.p11.c2" var_name="shareid" calculated_type="string" reported_type=""><description>Framingham Heart Study participant SHARe ID number</description><total><subject_profile><sex><male>25</male><female>22</female></sex></subject_profile><stats><stat n="47" nulls="0"/></stats></total></variable><variable id="phv00163427.v2.p11" var_name="INSERM_B" calculated_type="integer" reported_type="encoded,string"><description>INSERM batch number</description><comment>One control sample was run per batch of FHS samples</comment><total><subject_profile><sex><male>402</male><female>501</female></sex></subject_profile><stats><stat n="903" nulls="0" median="" min="" max=""/></stats></total></variable><variable id="phv00163427.v2.p11.c1" var_name="INSERM_B" calculated_type="integer" reported_type="encoded,string"><description>INSERM batch number</description><comment>One control sample was run per batch of FHS samples</comment><total><subject_profile><sex><male>377</male><female>479</female></sex></subject_profile><stats><stat n="856" nulls="0" median="" min="" max=""/></stats></total></variable><variable id="phv00163427.v2.p11.c2" var_name="INSERM_B" calculated_type="integer" reported_type="encoded,string"><description>INSERM batch number</description><comment>One control sample was run per batch of FHS samples</comment><total><subject_profile><sex><male>25</male><female>22</female></sex></subject_profile><stats><stat n="47" nulls="0" median="" min="" max=""/></stats></total></variable><variable id="phv00163428.v2.p11" var_name="INSERM_ID" calculated_type="string" reported_type="encoded,string"><description>Unique INSERM participant identifier</description><comment>Based on box number and position number for example: "Fram-7-99" refers to box 7, position 99.</comment><total><subject_profile><sex><male>402</male><female>501</female></sex></subject_profile><stats><stat n="903" nulls="0"/></stats></total></variable><variable id="phv00163428.v2.p11.c1" var_name="INSERM_ID" calculated_type="string" reported_type="encoded,string"><description>Unique INSERM participant identifier</description><comment>Based on box number and position number for example: "Fram-7-99" refers to box 7, position 99.</comment><total><subject_profile><sex><male>377</male><female>479</female></sex></subject_profile><stats><stat n="856" nulls="0"/></stats></total></variable><variable id="phv00163428.v2.p11.c2" var_name="INSERM_ID" calculated_type="string" reported_type="encoded,string"><description>Unique INSERM participant identifier</description><comment>Based on box number and position number for example: "Fram-7-99" refers to box 7, position 99.</comment><total><subject_profile><sex><male>25</male><female>22</female></sex></subject_profile><stats><stat n="47" nulls="0"/></stats></total></variable><variable id="phv00163429.v2.p11" var_name="plt_cont" calculated_type="enum_integer" reported_type="encoded"><description>Platelet contamination (sample: platelet poor plasma - citrate)</description><total><subject_profile><sex><male>402</male><female>501</female></sex></subject_profile><stats><stat n="903" nulls="0" mean_count="451.5" sd="573.5" median_count="451.5" min_count="46" max_count="857"/><enum code="0" count="857">No</enum><enum code="1" count="46">Yes</enum></stats></total></variable><variable id="phv00163429.v2.p11.c1" var_name="plt_cont" calculated_type="enum_integer" reported_type="encoded"><description>Platelet contamination (sample: platelet poor plasma - citrate)</description><total><subject_profile><sex><male>377</male><female>479</female></sex></subject_profile><stats><stat n="856" nulls="0" mean_count="428" sd="543.1" median_count="428" min_count="44" max_count="812"/><enum code="0" count="812">No</enum><enum code="1" count="44">Yes</enum></stats></total></variable><variable id="phv00163429.v2.p11.c2" var_name="plt_cont" calculated_type="enum_integer" reported_type="encoded"><description>Platelet contamination (sample: platelet poor plasma - citrate)</description><total><subject_profile><sex><male>25</male><female>22</female></sex></subject_profile><stats><stat n="47" nulls="0" mean_count="23.5" sd="30.41" median_count="23.5" min_count="2" max_count="45"/><enum code="0" count="45">No</enum><enum code="1" count="2">Yes</enum></stats></total></variable><variable id="phv00163430.v2.p11" var_name="mp_mean" calculated_type="integer" units="number/microL" reported_type="decimal, encoded"><description>Microparticle mean count (sample: platelet poor plasma - citrate)</description><total><subject_profile><sex><male>402</male><female>501</female></sex></subject_profile><stats><stat n="903" nulls="0" mean="5671" sd="2523" median="5352" min="989" max="18641"/><example count="3">5440</example><example count="3">3964</example><example count="3">3973</example><example count="3">8700</example><example count="2">5837</example><example count="2">5862</example><example count="2">9157</example><example count="2">3051</example><example count="2">4035</example><example count="2">4195</example></stats></total></variable><variable id="phv00163430.v2.p11.c1" var_name="mp_mean" calculated_type="integer" units="number/microL" reported_type="decimal, encoded"><description>Microparticle mean count (sample: platelet poor plasma - citrate)</description><total><subject_profile><sex><male>377</male><female>479</female></sex></subject_profile><stats><stat n="856" nulls="0" mean="5695" sd="2549" median="5362" min="989" max="18641"/><example count="3">5440</example><example count="3">3964</example><example count="3">3973</example><example count="2">5837</example><example count="2">5862</example><example count="2">9157</example><example count="2">3051</example><example count="2">4035</example><example count="2">2619</example><example count="2">5908</example></stats></total></variable><variable id="phv00163430.v2.p11.c2" var_name="mp_mean" calculated_type="integer" units="number/microL" reported_type="decimal, encoded"><description>Microparticle mean count (sample: platelet poor plasma - citrate)</description><total><subject_profile><sex><male>25</male><female>22</female></sex></subject_profile><stats><stat n="47" nulls="0" mean="5240" sd="1960" median="5175" min="1902" max="10072"/><example count="1">6928</example><example count="1">3435</example><example count="1">8110</example><example count="1">4195</example><example count="1">3785</example><example count="1">5432</example><example count="1">6541</example><example count="1">4044</example><example count="1">3795</example><example count="1">9108</example></stats></total></variable><variable id="phv00163431.v2.p11" var_name="mp_cd11" calculated_type="integer" units="number/microL" reported_type="decimal, encoded"><description>Total number of CD11a+ leukocyte microparticles in events (sample: platelet poor plasma - citrate)</description><total><subject_profile><sex><male>400</male><female>501</female></sex></subject_profile><stats><stat n="901" nulls="2" mean="65.73" sd="38.37" median="58" min="1" max="287"/><example count="18">61</example><example count="16">58</example><example count="16">53</example><example count="15">35</example><example count="14">32</example><example count="14">37</example><example count="13">65</example><example count="13">60</example><example count="13">33</example><example count="12">57</example></stats></total></variable><variable id="phv00163431.v2.p11.c1" var_name="mp_cd11" calculated_type="integer" units="number/microL" reported_type="decimal, encoded"><description>Total number of CD11a+ leukocyte microparticles in events (sample: platelet poor plasma - citrate)</description><total><subject_profile><sex><male>375</male><female>479</female></sex></subject_profile><stats><stat n="854" nulls="2" mean="66.16" sd="38.56" median="59" min="1" max="287"/><example count="18">61</example><example count="16">58</example><example count="15">53</example><example count="14">32</example><example count="14">35</example><example count="14">37</example><example count="13">60</example><example count="13">33</example><example count="12">57</example><example count="12">45</example></stats></total></variable><variable id="phv00163431.v2.p11.c2" var_name="mp_cd11" calculated_type="integer" units="number/microL" reported_type="decimal, encoded"><description>Total number of CD11a+ leukocyte microparticles in events (sample: platelet poor plasma - citrate)</description><total><subject_profile><sex><male>25</male><female>22</female></sex></subject_profile><stats><stat n="47" nulls="0" mean="57.85" sd="34.1" median="54" min="10" max="203"/><example count="4">55</example><example count="3">65</example><example count="2">71</example><example count="2">29</example><example count="2">51</example><example count="2">26</example><example count="2">30</example><example count="2">40</example><example count="1">118</example><example count="1">31</example></stats></total></variable><variable id="phv00163432.v2.p11" var_name="mp_cd235" calculated_type="integer" units="number/microL" reported_type="decimal, encoded"><description>Total number of CD235a+ erythrocyte microparticles in events (sample: platelet poor plasma - citrate)</description><total><subject_profile><sex><male>399</male><female>495</female></sex></subject_profile><stats><stat n="894" nulls="9" mean="287.8" sd="258.6" median="205" min="31" max="3742"/><example count="8">111</example><example count="7">93</example><example count="7">143</example><example count="7">190</example><example count="7">138</example><example count="7">187</example><example count="7">142</example><example count="7">150</example><example count="6">127</example><example count="6">84</example></stats></total></variable><variable id="phv00163432.v2.p11.c1" var_name="mp_cd235" calculated_type="integer" units="number/microL" reported_type="decimal, encoded"><description>Total number of CD235a+ erythrocyte microparticles in events (sample: platelet poor plasma - citrate)</description><total><subject_profile><sex><male>374</male><female>474</female></sex></subject_profile><stats><stat n="848" nulls="8" mean="287.9" sd="261.3" median="205.5" min="31" max="3742"/><example count="8">111</example><example count="7">143</example><example count="7">190</example><example count="7">138</example><example count="7">187</example><example count="7">150</example><example count="6">127</example><example count="6">208</example><example count="6">93</example><example count="6">129</example></stats></total></variable><variable id="phv00163432.v2.p11.c2" var_name="mp_cd235" calculated_type="integer" units="number/microL" reported_type="decimal, encoded"><description>Total number of CD235a+ erythrocyte microparticles in events (sample: platelet poor plasma - citrate)</description><total><subject_profile><sex><male>25</male><female>21</female></sex></subject_profile><stats><stat n="46" nulls="1" mean="284.9" sd="206" median="191" min="75" max="836"/><example count="2">140</example><example count="2">210</example><example count="1">206</example><example count="1">84</example><example count="1">634</example><example count="1">347</example><example count="1">93</example><example count="1">429</example><example count="1">337</example><example count="1">198</example></stats></total></variable><variable id="phv00163433.v2.p11" var_name="mp_cd144" calculated_type="integer" units="number/microL" reported_type="decimal, encoded"><description>Total number of CD144+ endothelial microparticles in events (sample: platelet poor plasma - citrate)</description><total><subject_profile><sex><male>396</male><female>494</female></sex></subject_profile><stats><stat n="890" nulls="13" mean="137.3" sd="73.89" median="131" min="7" max="535"/><example count="10">139</example><example count="10">145</example><example count="10">115</example><example count="10">136</example><example count="9">101</example><example count="8">102</example><example count="8">58</example><example count="8">50</example><example count="8">166</example><example count="8">105</example></stats></total></variable><variable id="phv00163433.v2.p11.c1" var_name="mp_cd144" calculated_type="integer" units="number/microL" reported_type="decimal, encoded"><description>Total number of CD144+ endothelial microparticles in events (sample: platelet poor plasma - citrate)</description><total><subject_profile><sex><male>371</male><female>472</female></sex></subject_profile><stats><stat n="843" nulls="13" mean="137.8" sd="74.45" median="131" min="7" max="535"/><example count="10">136</example><example count="9">101</example><example count="9">139</example><example count="9">145</example><example count="9">115</example><example count="8">102</example><example count="8">50</example><example count="8">166</example><example count="8">105</example><example count="7">58</example></stats></total></variable><variable id="phv00163433.v2.p11.c2" var_name="mp_cd144" calculated_type="integer" units="number/microL" reported_type="decimal, encoded"><description>Total number of CD144+ endothelial microparticles in events (sample: platelet poor plasma - citrate)</description><total><subject_profile><sex><male>25</male><female>22</female></sex></subject_profile><stats><stat n="47" nulls="0" mean="129.2" sd="63.13" median="125" min="22" max="266"/><example count="2">122</example><example count="2">42</example><example count="2">109</example><example count="1">32</example><example count="1">71</example><example count="1">57</example><example count="1">199</example><example count="1">58</example><example count="1">139</example><example count="1">135</example></stats></total></variable><variable id="phv00163434.v2.p11" var_name="mp_cd62e" calculated_type="integer" units="number/microL" reported_type="decimal, encoded"><description>Total number of CD62e+ endothelial microparticles in events (sample: platelet poor plasma - citrate)</description><total><subject_profile><sex><male>401</male><female>500</female></sex></subject_profile><stats><stat n="901" nulls="2" mean="61.11" sd="36.99" median="55" min="2" max="499"/><example count="22">48</example><example count="21">45</example><example count="18">42</example><example count="17">31</example><example count="17">37</example><example count="17">52</example><example count="17">44</example><example count="16">41</example><example count="16">46</example><example count="16">54</example></stats></total></variable><variable id="phv00163434.v2.p11.c1" var_name="mp_cd62e" calculated_type="integer" units="number/microL" reported_type="decimal, encoded"><description>Total number of CD62e+ endothelial microparticles in events (sample: platelet poor plasma - citrate)</description><total><subject_profile><sex><male>376</male><female>478</female></sex></subject_profile><stats><stat n="854" nulls="2" mean="61.58" sd="37.47" median="55" min="6" max="499"/><example count="21">48</example><example count="18">45</example><example count="17">37</example><example count="17">44</example><example count="16">31</example><example count="16">42</example><example count="16">46</example><example count="16">54</example><example count="15">62</example><example count="15">59</example></stats></total></variable><variable id="phv00163434.v2.p11.c2" var_name="mp_cd62e" calculated_type="integer" units="number/microL" reported_type="decimal, encoded"><description>Total number of CD62e+ endothelial microparticles in events (sample: platelet poor plasma - citrate)</description><total><subject_profile><sex><male>25</male><female>22</female></sex></subject_profile><stats><stat n="47" nulls="0" mean="52.7" sd="25.55" median="52" min="2" max="136"/><example count="3">52</example><example count="3">45</example><example count="3">63</example><example count="2">73</example><example count="2">67</example><example count="2">47</example><example count="2">41</example><example count="2">42</example><example count="2">27</example><example count="2">20</example></stats></total></variable><variable id="phv00163435.v2.p11" var_name="mp_annv" calculated_type="integer" units="number/microL" reported_type="decimal, encoded"><description>Total number Annexin V+ microparticles in events (sample: platelet poor plasma - citrate)</description><total><subject_profile><sex><male>398</male><female>492</female></sex></subject_profile><stats><stat n="890" nulls="13" mean="1298" sd="1096" median="953" min="6" max="6567"/><example count="4">233</example><example count="4">367</example><example count="3">805</example><example count="3">1416</example><example count="3">1241</example><example count="3">644</example><example count="3">200</example><example count="3">650</example><example count="3">224</example><example count="3">852</example></stats></total></variable><variable id="phv00163435.v2.p11.c1" var_name="mp_annv" calculated_type="integer" units="number/microL" reported_type="decimal, encoded"><description>Total number Annexin V+ microparticles in events (sample: platelet poor plasma - citrate)</description><total><subject_profile><sex><male>373</male><female>470</female></sex></subject_profile><stats><stat n="843" nulls="13" mean="1306" sd="1098" median="959" min="6" max="6567"/><example count="4">233</example><example count="4">367</example><example count="3">1416</example><example count="3">1241</example><example count="3">644</example><example count="3">200</example><example count="3">455</example><example count="3">1804</example><example count="3">725</example><example count="3">1367</example></stats></total></variable><variable id="phv00163435.v2.p11.c2" var_name="mp_annv" calculated_type="integer" units="number/microL" reported_type="decimal, encoded"><description>Total number Annexin V+ microparticles in events (sample: platelet poor plasma - citrate)</description><total><subject_profile><sex><male>25</male><female>22</female></sex></subject_profile><stats><stat n="47" nulls="0" mean="1161" sd="1057" median="817" min="20" max="5878"/><example count="1">1588</example><example count="1">443</example><example count="1">805</example><example count="1">316</example><example count="1">3537</example><example count="1">2000</example><example count="1">648</example><example count="1">571</example><example count="1">327</example><example count="1">202</example></stats></total></variable><variable id="phv00163436.v2.p11" var_name="mp_cd41" calculated_type="integer" units="number/microL" reported_type="decimal, encoded"><description>Total number of CD31+CD41+ platelet microparticles in events (sample: platelet poor plasma - citrate)</description><total><subject_profile><sex><male>397</male><female>495</female></sex></subject_profile><stats><stat n="892" nulls="11" mean="1126" sd="1081" median="785" min="10" max="7763"/><example count="4">379</example><example count="4">544</example><example count="4">268</example><example count="3">948</example><example count="3">684</example><example count="3">285</example><example count="3">552</example><example count="3">1219</example><example count="3">286</example><example count="3">254</example></stats></total></variable><variable id="phv00163436.v2.p11.c1" var_name="mp_cd41" calculated_type="integer" units="number/microL" reported_type="decimal, encoded"><description>Total number of CD31+CD41+ platelet microparticles in events (sample: platelet poor plasma - citrate)</description><total><subject_profile><sex><male>372</male><female>474</female></sex></subject_profile><stats><stat n="846" nulls="10" mean="1129" sd="1083" median="786.5" min="10" max="7763"/><example count="4">379</example><example count="4">544</example><example count="4">268</example><example count="3">948</example><example count="3">684</example><example count="3">285</example><example count="3">552</example><example count="3">1219</example><example count="3">286</example><example count="3">362</example></stats></total></variable><variable id="phv00163436.v2.p11.c2" var_name="mp_cd41" calculated_type="integer" units="number/microL" reported_type="decimal, encoded"><description>Total number of CD31+CD41+ platelet microparticles in events (sample: platelet poor plasma - citrate)</description><total><subject_profile><sex><male>25</male><female>21</female></sex></subject_profile><stats><stat n="46" nulls="1" mean="1074" sd="1044" median="765.5" min="51" max="5233"/><example count="1">331</example><example count="1">737</example><example count="1">5233</example><example count="1">3668</example><example count="1">347</example><example count="1">899</example><example count="1">540</example><example count="1">689</example><example count="1">1962</example><example count="1">783</example></stats></total></variable><variable id="phv00163437.v2.p11" var_name="mp_cd31" calculated_type="integer" units="number/microL" reported_type="decimal, encoded"><description>Total number of CD31+CD41- endothelial microparticles in events (sample: platelet poor plasma - citrate)</description><total><subject_profile><sex><male>396</male><female>496</female></sex></subject_profile><stats><stat n="892" nulls="11" mean="89.98" sd="77.66" median="71" min="0" max="1017"/><example count="24">0</example><example count="13">44</example><example count="13">66</example><example count="12">52</example><example count="11">39</example><example count="9">118</example><example count="9">140</example><example count="9">43</example><example count="9">74</example><example count="9">61</example></stats></total></variable><variable id="phv00163437.v2.p11.c1" var_name="mp_cd31" calculated_type="integer" units="number/microL" reported_type="decimal, encoded"><description>Total number of CD31+CD41- endothelial microparticles in events (sample: platelet poor plasma - citrate)</description><total><subject_profile><sex><male>371</male><female>474</female></sex></subject_profile><stats><stat n="845" nulls="11" mean="89.9" sd="78.32" median="72" min="0" max="1017"/><example count="24">0</example><example count="12">44</example><example count="11">39</example><example count="11">52</example><example count="11">66</example><example count="9">118</example><example count="9">74</example><example count="9">61</example><example count="9">107</example><example count="9">22</example></stats></total></variable><variable id="phv00163437.v2.p11.c2" var_name="mp_cd31" calculated_type="integer" units="number/microL" reported_type="decimal, encoded"><description>Total number of CD31+CD41- endothelial microparticles in events (sample: platelet poor plasma - citrate)</description><total><subject_profile><sex><male>25</male><female>22</female></sex></subject_profile><stats><stat n="47" nulls="0" mean="91.32" sd="65.23" median="66" min="5" max="264"/><example count="3">64</example><example count="2">57</example><example count="2">25</example><example count="2">66</example><example count="1">127</example><example count="1">71</example><example count="1">89</example><example count="1">199</example><example count="1">62</example><example count="1">135</example></stats></total></variable><variable id="phv00163438.v2.p11" var_name="IDTYPE" calculated_type="enum_integer" reported_type="integer"><description>Framingham Heart Study cohort group</description><total><subject_profile><sex><male>402</male><female>501</female></sex></subject_profile><stats><stat n="903" nulls="0" mean_count="903" median_count="903" min_count="903" max_count="903"/><enum code="1" count="903">Offspring Cohort</enum></stats></total></variable><variable id="phv00163438.v2.p11.c1" var_name="IDTYPE" calculated_type="enum_integer" reported_type="integer"><description>Framingham Heart Study cohort group</description><total><subject_profile><sex><male>377</male><female>479</female></sex></subject_profile><stats><stat n="856" nulls="0" mean_count="856" median_count="856" min_count="856" max_count="856"/><enum code="1" count="856">Offspring Cohort</enum></stats></total></variable><variable id="phv00163438.v2.p11.c2" var_name="IDTYPE" calculated_type="enum_integer" reported_type="integer"><description>Framingham Heart Study cohort group</description><total><subject_profile><sex><male>25</male><female>22</female></sex></subject_profile><stats><stat n="47" nulls="0" mean_count="47" median_count="47" min_count="47" max_count="47"/><enum code="1" count="47">Offspring Cohort</enum></stats></total></variable></data_table>
